Chang Baeg Lim

Title: Chang Baeg Lim: Innovator in Colonic Drug Delivery

Introduction

Chang Baeg Lim is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in drug delivery systems. His innovative work focuses on enhancing the effectiveness of drug delivery to the colon, which is crucial for treating various gastrointestinal conditions.

Latest Patents

Chang Baeg Lim holds a patent for a composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides. This patent describes a colonic drug delivery composition that includes a first polysaccharide and a second polysaccharide. Both polysaccharides are designed to be degradable by colonic enzymes and are mixed at an environmental pH of about 7 or above, without the use of a cross-linking agent. The invention also encompasses a colon-selective pharmaceutical composition and dosage form for the oral delivery of a drug, diagnostic reagent, or a mixture thereof. The method of preparing this colonic drug delivery composition is also disclosed in the patent.

Career Highlights

Chang Baeg Lim is associated with Samyang Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for drug delivery, which can significantly improve patient outcomes.

Collaborations

Chang Baeg Lim has collaborated with notable colleagues, including Seung Seo Lee and Chaul Min Pai. Their combined expertise contributes to the ongoing advancements in pharmaceutical technologies.

Conclusion

Chang Baeg Lim's contributions to colonic drug delivery systems exemplify the importance of innovation in the pharmaceutical industry. His work not only enhances drug efficacy but also paves the way for future advancements in medical treatments.